Investigation into conolidine has brought about discovery of an opioid receptor in the human body named ACKR3/CXCR7. ACKR3 appears to be one of the most desired target for conolidine, which also disregards the other four classical opioid receptors(3). That is rising like a promising alternative drug. Much more importantly, https://georgesi531eim5.jts-blog.com/profile